Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 14c, Offers FY20 and FY21 Guidance
November 5, 2020 7:03 AM ESTBristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.63, $0.14 better than the analyst estimate of $1.49. Revenue for the quarter came in at $10.5 billion versus the consensus estimate of $10.33 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2020 EPS of $6.25-$6.35, versus the consensus of... More
